CVS Eliminates 72 Hyperinflated Drugs, Saving $1.2 Billion in 2020
CVS has removed 72 high-priced drugs from its formulary. This move has led to $1.2 billion in savings last year [...]
Blues Plans in Lawsuit Claim CVS Inflated Generic Prices
Six insurers under the Blue Cross Blue Shield umbrella are suing CVS Health, claiming the pharmacy chain inflated generic drug [...]
Report: Gene Therapies Could Add $45B to Health Costs
A new report from CVS Health suggests gene therapies could add an additional $45 billion to health care costs over [...]
CVS Releases Health Trends Report for 2020
CVS Health this week released its "Health Trends 2020" report which identifies six key trends in the health care industry, [...]
Advertisement
